Literature DB >> 35175375

Cerebral blood flow imaging in MR-negative SARS-CoV-2-related encephalitis with abnormal psychosis.

Kazuma Ota1, Masamune Kimura2, Michi Kawamoto1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35175375      PMCID: PMC8852877          DOI: 10.1007/s00259-022-05728-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


× No keyword cloud information.
SARS-CoV-2 can invade the nervous system and cause neuronal damage, including encephalitis [1]. A 48-year-old man presented with fever and dyspnea (day 0). He was diagnosed with COVID-19 by a positive nasopharyngeal swab of SARS-CoV-2. After the admission, his respiratory condition improved through steroid therapy. He was discharged on day 17. However, he presented to our hospital with an acute severe attention disturbance and excessive masturbation on day 22. His cognitive function was normal and had no paralysis. Blood chemistry analysis revealed no inflammatory response, and a wide screening for antibodies associated with autoimmune encephalitis yielded negative results. The cerebrospinal fluid (CSF) analysis showed a normal cell count; however, the polymerase chain reaction test for SARS-CoV-2 in CSF revealed positive. Brain magnetic resonance imaging (MRI) (day 24, A; fluid-attenuated inversion recovery) revealed no abnormalities, but N-isopropyl-p-[123I] iodoamphetamine (IMP) single-photon emission computed tomography (SPECT) (day 27, B; qualitative surface views and Z-score views of functional increase by three-dimensional stereotactic surface projection analysis in NEUROSTAT [2]; the whole brain was defined as reference regions for normalization) showed increased uptake in the bilateral thalamus, septal region, and posterior cingulate gyrus. Based on the CSF and the SPECT findings, he was diagnosed with SARS-CoV-2-related encephalitis. Methylprednisolone and intravenous immunoglobulin were started. Following treatment, his psychosis gradually improved, and he fully recovered on day 73. Repeat 123I-IMP SPECT showed improvement in the hyperperfusion areas (C). Some cases of SARS-CoV-2-related encephalitis do not show any abnormalities on MRI and require additional imaging [3]. In our case, there was no edematous change on MRI. This might have been because the encephalitis was not too severe to cause edema or early treatment contributed to spare the morphological changes. From a neurological point of view, the thalamus contributes to attention control [4], and septal stimulation elicits a compulsion to masturbate [5]. These localizations were consistent with SPECT findings; thus, the patient’s hyperperfusion area might have shown the inflammation with hyperstimulation to the surrounding systems.
  5 in total

Review 1.  Neurological control of human sexual behaviour: insights from lesion studies.

Authors:  Amee D Baird; Sarah J Wilson; Peter F Bladin; Michael M Saling; David C Reutens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-22       Impact factor: 10.154

Review 2.  Thalamic functions in distributed cognitive control.

Authors:  Michael M Halassa; Sabine Kastner
Journal:  Nat Neurosci       Date:  2017-11-28       Impact factor: 24.884

3.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

Authors:  S Minoshima; K A Frey; R A Koeppe; N L Foster; D E Kuhl
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

Review 4.  Nervous system involvement after infection with COVID-19 and other coronaviruses.

Authors:  Yeshun Wu; Xiaolin Xu; Zijun Chen; Jiahao Duan; Kenji Hashimoto; Ling Yang; Cunming Liu; Chun Yang
Journal:  Brain Behav Immun       Date:  2020-03-30       Impact factor: 7.217

5.  Postinfectious Neurologic Complications in COVID-19: A Complex Case Report.

Authors:  Pietro Tiraboschi; Rubjona Xhani; Simone M Zerbi; Angelo Corso; Isabella Martinelli; Laura Fusi; Giampiero Grampa; Andrea Lombardo; Paola Cavalcante; Cristina Cappelletti; Francesca Andreetta; Alberto Sironi; Alberto Redolfi; Cristina Muscio
Journal:  J Nucl Med       Date:  2021-05-20       Impact factor: 10.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.